CDKN1A and glioblastoma: After treating two doxorubicin-induced senescence GBM cells (PGC62 and GSC0117) with 10 μM GDC-0879, we observed a significant decrease in senescent SA-β-gal staining and a significant downregulation of P21 mRNA expression (Fig. S10F–I).